Evaluation of the interferon-γ release assay in healthcare workers

International Archives of Occupational and Environmental Health

Volumn 81, Issue 3, 2008, Pages 295-300

  Nienhaus, Albert ^a   Schablon, A ^b   Le Bacle C ^c   Siano, B ^c   Diel, R ^d  

^a Institution for Statutory Accident Insurance   (Germany)

^b HAMBURG UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Health care worker; Interferon release assay; Latent TB infection; Tuberculin skin test

Indexed keywords

BCG VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; BCG VACCINATION; BIRTHPLACE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; GAMMA INTERFERON RELEASE ASSAY; GERMANY; HEALTH CARE PERSONNEL; HUMAN; IMMUNOLOGICAL PROCEDURES; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; RISK FACTOR; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEALTH PERSONNEL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SKIN TESTS; TUBERCULOSIS;

EID: 36549009114     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00420-007-0212-1     Document Type: Article

References (24)

1. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356(9235):1099-1104
2. ATS - American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161(4 Pt 2):S221-S247
3. BTS - Joint Tuberculosis Committee of the British Thoracic Society (2000) Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 55:887-901
4. CDC (2005) Guidelines for the investigation of contacts of persons with infectious tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 54:1-37
5. Diel R, Ernst M, Doscher G, Visuri-Karbe L, Greinert U, Niemann S, Nienhaus A, Lange C (2006a) Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 28(1):16-23
6. Diel R, Nienhaus A, Lange C, Schaberg T (2006b) Cost-optimisation of screening for latent tuberculosis in close contacts. Eur Respir J 28(1):35-44
7. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T (2006) Screening for tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 27(5): 442-448
8. Hosmer D, Lemeshow S (2000) Applied logistic regression. Wiley, New York
9. Lange C, Schaberg T, Diel R, Greinert U (2006) Current concepts in the diagnosis of tuberkulosis. Deutsch Med Wochenschr 131:341-347
10. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178(5):1274-1282
11. Mazurek GH, Hereb J, Lobue P, Iademarco MF, Metchock B, Vernon A (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54(RR-15):49-55
12. Menzies D, Pai M, Comstock G (2007) Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 146:340-354
13. Menzies D (2000) What does tuberculin reactivity after Bacille Calmette-Guerin vaccination tell us? Clin infect Dis 31(Suppl 3):S71-74
14. Nahid P, Pai M, Hopewell PC (2006) Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 3:103-110
15. NICE - National Institute for Health and Clinical Excellence (2006) Clinical Guideline 33. Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE, London, UK. http://www.nice.org.uk
16. Pai M (2005) Alternatives to the tuberculin skin test: interferon-γ assays in the diagnosis of Mycobacterium tuberculosis infection. Indian J Med Microbiol 23(3): 151-158
17. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta D, Narang P, Daley C, Granich R, Mazurek G, Reingold A, Riley L, Colford J (2005) Mycobacterium tuberculosis infection in health care workers in rural India: Comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293:2746-2755
18. Pai M, Kalantri S, Dheda K (2006a) New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis. Expert Rev Mol Diagn 6(3):413-422
19. Pai M, Joshi R, Dogra S, Mendriatta D, Narang P, Kalantri S, Reingold A, Colford J, Riley L, Menzies D (2006b) Serial testing of health care workers for tuberculosis using interferon-γ assay. AJRCCM 174(3):349-355
20. RKI - Robert Koch-Institut (2006) Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2004 (Report of the Epidemiology of Tuberculosis in Germany 2004), Berlin
21. Singh D, Sutton C, Woodcock A (2001) Repeat tuberculin testing in BCG-vaccinated subjects in the United Kingdom. The booster effect varies with the time of reading. Am J Respir Crit Care Med 164(6):962-964
22. Stop TB Partnership, WHO (2006) The Global Plan to Stop TB 2006-2015. WHO Geneva, Switzerland
23. Von Pirquet C (1909) Frequency of tuberculosis in children JAMA LII (9)
24. WHO (2005) Global tuberculosis control. Surveillance, planning, financing. WHO Report 2005, Geneva, Switzerland, pp 1-247